TY - JOUR
T1 - Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic
AU - Padilla-Rivas, Gerardo R.
AU - Delgado-Gallegos, Juan Luis
AU - Garza-Treviño, Gerardo
AU - Galan-Huerta, Kame A.
AU - G-Buentello, Zuca
AU - Roacho-Pérez, Jorge A.
AU - Santoyo-Suarez, Michelle Giovana
AU - Franco-Villareal, Hector
AU - Leyva-Lopez, Ahidée
AU - Estrada, Ana
AU - Moreno-Cuevas, Jorge E.
AU - Ramos-Jimenez, Javier
AU - Rivas-Estrilla, Ana M.
AU - Garza-Treviño, Elsa N.
AU - Islas, Jose Francisco
N1 - Funding Information:
The authors acknowledge the equal collaboration of all involved institutions.
Publisher Copyright:
Copyright © 2022 Padilla-Rivas, Delgado-Gallegos, Garza-Treviño, Galan-Huerta, G-Buentello, Roacho-Pérez, Santoyo-Suarez, Franco-Villareal, Leyva-Lopez, Estrada-Rodriguez, Moreno-Cuevas, Ramos-Jimenez, Rivas-Estrilla, Garza-Treviño and Islas.
PY - 2022/11/10
Y1 - 2022/11/10
N2 - Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Over the past couple of years and with the surge of the COVID-19 pandemic, mortality from CVDs has been slightly overshadowed by those due to COVID-19, although it was during the peak of the pandemic. In the present study, patients with CVDs (CVDs; n = 41,883) were analyzed to determine which comorbidities had the largest impact on overall patient mortality due to their association with both diseases (n = 3,637). Obesity, hypertension, and diabetes worsen health in patients diagnosed positive for COVID-19. Hence, they were included in the overview of all patients with CVD. Our findings showed that 1,697 deaths were attributable to diabetes (p < 0.001) and 987 deaths to obesity (p < 0.001). Lastly, 2,499 deaths were attributable to hypertension (p < 0.001). Using logistic regression modeling, we found that diabetes (OR: 1.744, p < 0.001) and hypertension (OR: 2.179, p < 0.001) significantly affected the mortality rate of patients. Hence, having a CVD diagnosis, with hypertension and/or diabetes, seems to increase the likelihood of complications, leading to death in patients diagnosed positive for COVID-19.
AB - Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Over the past couple of years and with the surge of the COVID-19 pandemic, mortality from CVDs has been slightly overshadowed by those due to COVID-19, although it was during the peak of the pandemic. In the present study, patients with CVDs (CVDs; n = 41,883) were analyzed to determine which comorbidities had the largest impact on overall patient mortality due to their association with both diseases (n = 3,637). Obesity, hypertension, and diabetes worsen health in patients diagnosed positive for COVID-19. Hence, they were included in the overview of all patients with CVD. Our findings showed that 1,697 deaths were attributable to diabetes (p < 0.001) and 987 deaths to obesity (p < 0.001). Lastly, 2,499 deaths were attributable to hypertension (p < 0.001). Using logistic regression modeling, we found that diabetes (OR: 1.744, p < 0.001) and hypertension (OR: 2.179, p < 0.001) significantly affected the mortality rate of patients. Hence, having a CVD diagnosis, with hypertension and/or diabetes, seems to increase the likelihood of complications, leading to death in patients diagnosed positive for COVID-19.
UR - http://www.scopus.com/inward/record.url?scp=85142505960&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142505960&partnerID=8YFLogxK
U2 - 10.3389/fpubh.2022.1008565
DO - 10.3389/fpubh.2022.1008565
M3 - Article
C2 - 36438268
SN - 2296-2565
VL - 10
SP - 1008565
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 1008565
ER -
